Employees Retirement System of Texas Sells 1,600 Shares of Stryker Corporation $SYK

Employees Retirement System of Texas cut its stake in shares of Stryker Corporation (NYSE:SYK) by 0.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 200,200 shares of the medical technology company’s stock after selling 1,600 shares during the period. Employees Retirement System of Texas owned 0.05% of Stryker worth $74,008,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Sei Investments Co. grew its holdings in Stryker by 1.8% in the 3rd quarter. Sei Investments Co. now owns 427,634 shares of the medical technology company’s stock valued at $158,090,000 after buying an additional 7,655 shares in the last quarter. Crux Wealth Advisors grew its stake in shares of Stryker by 1.0% in the third quarter. Crux Wealth Advisors now owns 3,384 shares of the medical technology company’s stock valued at $1,251,000 after acquiring an additional 34 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new position in Stryker during the third quarter worth about $19,584,000. SageView Advisory Group LLC raised its stake in Stryker by 176.5% in the 3rd quarter. SageView Advisory Group LLC now owns 4,104 shares of the medical technology company’s stock worth $1,517,000 after purchasing an additional 2,620 shares in the last quarter. Finally, Kepler Cheuvreux Suisse SA bought a new stake in Stryker in the 3rd quarter valued at about $27,952,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on the stock. Needham & Company LLC raised their target price on shares of Stryker from $448.00 to $454.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Sanford C. Bernstein boosted their price target on Stryker from $450.00 to $465.00 and gave the company an “outperform” rating in a research note on Friday, January 9th. Raymond James Financial raised Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price target on the stock in a research report on Tuesday, January 6th. Evercore set a $390.00 price objective on Stryker in a report on Monday, January 5th. Finally, TD Cowen downgraded Stryker from a “buy” rating to a “hold” rating and set a $387.00 target price for the company. in a research report on Monday, January 26th. Fourteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, Stryker presently has an average rating of “Moderate Buy” and a consensus price target of $428.61.

Stryker Stock Performance

NYSE SYK opened at $337.23 on Friday. The firm’s 50 day simple moving average is $365.42 and its 200 day simple moving average is $368.08. The firm has a market capitalization of $129.05 billion, a price-to-earnings ratio of 40.15, a P/E/G ratio of 2.02 and a beta of 0.85. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66. Stryker Corporation has a 1 year low of $328.23 and a 1 year high of $404.87.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating the consensus estimate of $4.40 by $0.07. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The business had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.12 billion. During the same period in the previous year, the business earned $4.01 earnings per share. The company’s revenue was up 11.4% on a year-over-year basis. As a group, research analysts expect that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be given a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Tuesday, March 31st. Stryker’s dividend payout ratio is currently 41.90%.

More Stryker News

Here are the key news stories impacting Stryker this week:

• Positive Sentiment: Citi/analysts flag potential upside beyond the immediate disruption, suggesting a “90‑day catalyst” window where recovery or additional clarity could present buying opportunities. Cyberattack Knocks Stryker Stock (SYK) — But Citi Sees Upside with ‘90-Day Catalyst Watch’
• Neutral Sentiment: Stryker confirmed it identified a cybersecurity incident disrupting global IT/Micro‑services and is investigating; the company is communicating with customers and assessing operational impact (statement ongoing). Stryker Reports Cybersecurity Incident Disrupting Global IT Systems
• Negative Sentiment: Reuters reports the outage is causing widespread disruption to Stryker’s business operations, including the ability to process orders, manufacture products and ship to customers — a direct revenue and supply‑chain hit until systems are restored. Stryker flags disruption to orders, manufacturing a day after cyberattack
• Negative Sentiment: Multiple outlets report an Iran‑linked group (Handala) claimed a destructive wiper attack, alleging ~200,000 devices wiped and ~50TB of data seized — escalation that raises risks of prolonged outages, data breach costs and regulatory scrutiny. Stryker Cyberattack Update: Iran-Linked Handala Group Claims Destructive Wiper Attack on Medical Tech Giant
• Negative Sentiment: Market reaction: coverage shows SYK shares fell ~3–4% on initial reports as investors priced in operational disruption and uncertainty; trading volume has been above average. Stryker (SYK) Stock Plunges 3.6% Following Major Cyberattack Claim by Iran-Linked Hackers

Insiders Place Their Bets

In related news, Director Ronda E. Stryker sold 250,000 shares of the firm’s stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total value of $90,730,000.00. Following the sale, the director directly owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. This trade represents a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 5.90% of the stock is owned by company insiders.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.